XML 16 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 719 $ 947
Restricted cash 31 15
Trade receivables, net 2,094 1,998
Inventories, net 1,655 1,544
Prepaid expenses and other current assets 852 1,092
Total current assets 5,351 5,596
Property, plant and equipment, net 1,789 1,707
Intangible assets, net 5,652 6,456
Goodwill 11,171 11,183
Deferred tax assets, net 2,188 2,101
Other non-current assets 389 307
Total assets 26,540 27,350
Current liabilities:    
Accounts payable 667 719
Accrued and other current liabilities 3,386 3,133
Current portion of long-term debt 453 450
Total current liabilities 4,506 4,302
Acquisition-related contingent consideration 248 253
Non-current portion of long-term debt 21,054 21,938
Deferred tax liabilities, net 169 163
Other non-current liabilities 805 776
Total liabilities 26,782 27,432
Commitments and contingencies (Note 17)
Deficit    
Common shares, no par value, unlimited shares authorized, 367,695,267 and 365,238,917 issued and outstanding at September 30, 2024 and December 31, 2023, respectively 10,489 10,423
Additional paid-in capital 201 214
Accumulated deficit (9,917) (9,778)
Accumulated other comprehensive loss (1,947) (1,881)
Total Bausch Health Companies Inc. shareholders’ deficit (1,174) (1,022)
Noncontrolling interest 932 940
Total deficit (242) (82)
Total liabilities and deficit $ 26,540 $ 27,350